Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYDROXYPROPYL CELLULOSE vs IBANDRONATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

HYDROXYPROPYL CELLULOSE vs IBANDRONATE: Safety Overview

Metric HYDROXYPROPYL CELLULOSE IBANDRONATE
Total FAERS Reports 296 10,178
Deaths Reported 0 236
Death Rate N/A 2.3%
Hospitalizations 3 1,420
Average Patient Age 64.1 yrs 69.0 yrs
% Female Patients 91.2% 95.4%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 30, 2012
Manufacturer Bausch & Lomb Incorporated Eugia US LLC
Route OPHTHALMIC INTRAVENOUS
Marketing Status Discontinued Discontinued